| Primary |
| Product Used For Unknown Indication |
34.2% |
| Torticollis |
10.4% |
| Migraine |
9.3% |
| Skin Wrinkling |
7.6% |
| Muscle Spasticity |
7.3% |
| Hypertonic Bladder |
4.9% |
| Hyperhidrosis |
3.6% |
| Blepharospasm |
2.6% |
| Pain |
2.4% |
| Drug Use For Unknown Indication |
2.3% |
| Headache |
2.1% |
| Neurogenic Bladder |
1.9% |
| Depression |
1.8% |
| Hypertension |
1.7% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Dystonia |
1.5% |
| Muscle Spasms |
1.4% |
| Epilepsy |
1.3% |
| Convulsion |
1.1% |
| Anxiety |
1.0% |
|
| Drug Ineffective |
23.3% |
| Muscular Weakness |
10.8% |
| Therapeutic Response Decreased |
9.6% |
| Eyelid Ptosis |
6.2% |
| Headache |
5.5% |
| Dysphagia |
5.3% |
| Asthenia |
4.1% |
| Dyspnoea |
3.7% |
| Neck Pain |
3.2% |
| Respiratory Failure |
3.2% |
| Injection Site Pain |
3.0% |
| Rash |
3.0% |
| Botulism |
2.5% |
| Dizziness |
2.5% |
| Nausea |
2.5% |
| Urosepsis |
2.5% |
| Wrong Technique In Drug Usage Process |
2.5% |
| Pain |
2.3% |
| Urinary Tract Infection |
2.3% |
| Death |
2.1% |
|
| Secondary |
| Product Used For Unknown Indication |
33.0% |
| Torticollis |
15.9% |
| Pain |
7.5% |
| Muscle Spasticity |
6.3% |
| Depression |
3.2% |
| Drug Use For Unknown Indication |
2.9% |
| Blood Pressure |
2.8% |
| Myalgia |
2.8% |
| Skin Wrinkling |
2.8% |
| Migraine |
2.4% |
| Gastrooesophageal Reflux Disease |
2.4% |
| Muscle Spasms |
2.3% |
| Muscle Tightness |
2.3% |
| Headache |
2.1% |
| Back Pain |
2.0% |
| Bronchitis Chronic |
1.9% |
| Dystonia |
1.9% |
| Epilepsy |
1.9% |
| Blepharospasm |
1.8% |
| Hyperhidrosis |
1.8% |
|
| Therapeutic Response Decreased |
13.5% |
| Urosepsis |
8.9% |
| Muscular Weakness |
8.5% |
| Respiratory Failure |
8.5% |
| Asthenia |
8.2% |
| Dysphonia |
5.0% |
| Drug Ineffective |
4.3% |
| Dysphagia |
4.3% |
| Respiratory Arrest |
4.3% |
| Guillain-barre Syndrome |
3.9% |
| Vocal Cord Paralysis |
3.9% |
| Eating Disorder |
3.2% |
| Headache |
3.2% |
| Hemiparesis |
3.2% |
| Rash Generalised |
3.2% |
| Convulsion |
2.8% |
| Death |
2.8% |
| Eyelid Ptosis |
2.8% |
| Nervous System Disorder |
2.8% |
| Pain |
2.8% |
|
| Concomitant |
| Dystonia |
17.2% |
| Drug Use For Unknown Indication |
14.6% |
| Hypertension |
8.9% |
| Migraine |
7.0% |
| Pain |
5.7% |
| Anxiety |
5.1% |
| Insomnia |
4.5% |
| Blood Cholesterol Increased |
3.8% |
| Depression |
3.8% |
| Hypertonic Bladder |
3.8% |
| Meige's Syndrome |
3.8% |
| Convulsion |
3.2% |
| Multiple Sclerosis |
3.2% |
| Breakthrough Pain |
2.5% |
| Fibromyalgia |
2.5% |
| Torticollis |
2.5% |
| Crohn's Disease |
1.9% |
| Facial Pain |
1.9% |
| Hepatitis C |
1.9% |
| Hypothyroidism |
1.9% |
|
| Vision Blurred |
23.3% |
| Deafness Unilateral |
16.7% |
| Diarrhoea |
6.7% |
| Off Label Use |
6.7% |
| Pain |
6.7% |
| Weight Decreased |
6.7% |
| Accidental Exposure |
3.3% |
| Dermatofibrosarcoma Protuberans |
3.3% |
| Enterococcal Sepsis |
3.3% |
| Incorrect Dose Administered |
3.3% |
| Injection Site Pruritus |
3.3% |
| Musculoskeletal Pain |
3.3% |
| Pulmonary Embolism |
3.3% |
| Swelling Face |
3.3% |
| Urinary Tract Infection |
3.3% |
| Visual Acuity Reduced |
3.3% |
|
| Interacting |
| Asthma |
20.0% |
| Meige's Syndrome |
20.0% |
| Oesophageal Spasm |
20.0% |
| Off Label Use |
20.0% |
| Polycystic Ovaries |
20.0% |
|
| Drug Interaction |
50.0% |
| Headache |
50.0% |
|
